From: N6-methyladenosine modification—a key player in viral infection
Type | Virus | Protein | Biological function | Refs. |
---|---|---|---|---|
SARS-CoV-2 | METTL3 | Enhance m6A modification of SARS-CoV-2 RNA, viral load, and proviral gene expression | [52] | |
Interacts with the N region of RdRp | [54] | |||
Inhibits RIG-I binding to SARS-CoV-2 RNA | [52] | |||
RBM15 | Regulates the expression of multiple target genes | [55] | ||
RNA virus | Exacerbates the inflammatory response and promotes cell death signaling pathway in COVID-19 | |||
HIV-1 | METTL3 | Promotes Gag protein expression and the level of capsid p24 release | [75] | |
METTL14 | ||||
YTHDF1-3 | Binds with HIV-1 RNA to negatively regulate HIV-1 post-entry infection by blocking viral reverse transcription | |||
KSHV | YTHDC1 | Binds to m6A sites on the RTA pre-mRNA | [85] | |
FTO | Decrease m6A level and enhanced TPA induction of KSHV lytic gene expression | |||
YTHDF2 | Decrease the half-life of KSHV transcripts | [86] | ||
EBV | METTL14 | Cooperates with EBNA3C to promote cell growth and proliferation | [81] | |
DNA virus | Increases the tumorigenic activity of EBV-transformed cells | |||
METTL3 | BZLF1 represses METTL3 expression by binding to promoter | [82] | ||
Promotes the production of progeny virions and expression of the late viral lytic protein BKRF4, BALF4 | [28] | |||
Promotes EBNA2 expression | [83] | |||
YTHDF1 | Promotes the binding of RNA degradation complexes (ZAP, DDX17, and DCP2) to the mRNAs of BZLF1 and BRLF1 to suppress EBV infection and replication | [84] | ||
YTHDF2 | Increases KLF4 mRNA instability | [82] |